跳至主要内容
临床试验/NCT01277237
NCT01277237已完成3 期

The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease

University of Edinburgh1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2010年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
50
试验地点
1
主要终点
Liver appearance on ultrasound

研究概览

简要总结

There is preliminary evidence that Omega 3, a compound naturally found in fish oil, reduces the amount of fat stored in the liver and improves liver function. The purpose of this study is to see whether this observation is correct.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • a diagnosis of non-alcoholic fatty liver disease
  • fatty infiltration on ultrasound
  • abnormal serum liver function tests.

排除标准

  • any other identified cause of chronic liver disease
  • the prescription of medication which would cause non-alcoholic fatty liver - disease (e.g. tamoxifen)
  • already taking supplementary fish oil
  • alcohol intake of >20g/day for women, >40g/ day for men
  • known allergy to fish oil
  • on anticoagulants (antiplatelets are permitted)
  • severe heart failure (NYHA class IV)
  • pregnancy/ lactation
  • age under 18 years.

研究组 & 干预措施

Omacor

Active Comparator

干预措施: Omacor (Drug)

Lactose tablet

Placebo Comparator

干预措施: lactose tablet (Drug)

结局指标

主要结局

Liver appearance on ultrasound

时间窗: 6 months

The primary endpoint is improvement in grading on ultrasound assessment at six months. Liver brightness and posterior attenuation on ultrasound has previously been shown to correlate significantly with fat scores on liver biopsy.

次要结局

  • hepatocyte mitochondrial function(6 months)
  • Liver function tests(6 months)
  • Health-related Quality of Life(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验